Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL
Clinical trial NCT07195799 · RECRUITING
Trial details
- NCT number
- NCT07195799
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2027-12-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.